Patients with advanced dementia should have increased access to comprehensive care wherever they live, including the facilities in which they spend th... More »
PHILADELPHIA – Leuprolide acetate, in combination with an acetylcholinesterase inhibitor, helped to preserve cognitive function in Alzheimer’s disease patients in an exploratory study.
The <a...
*Article updated 12/18/14
The massive $1.1 trillion spending bill that was approved by Congress before it left for an extended recess included several provisions aimed at bolstering...
BERLIN – Chronic use of benzodiazepines by elderly patients is associated with a 43%-51% increased risk of being diagnosed with Alzheimer’s disease 5-10 years later, according to a large case-control...
Recently, an article in JAMA Internal Medicine suggested that more than 50% of nursing home patients with advanced dementia are on “medications of questionable benefit.” The <a...
Imaging to assess brain microstructure identified increased fractional anisotropy in the anterior right arcuate fasciculus of patients with chronic fatigue syndrome, which was not present in age- and...
Our relationship with vitamins and supplements may be approach-avoidance. On one hand, if they are beneficial and patients are motivated to take them, we do not complain. This is likely a marker of...
VIENNA – By age 4 years, the children of women who were overweight or obese before their pregnancy scored 3-4 points below normal on measures of neurocognitive development.
The children showed...
Benzodiazepine use for 3 months or more is associated with a significantly increased likelihood of developing Alzheimer’s disease, and longer exposure is associated with greater odds, according to...
Most nursing home residents with advanced dementia receive "medications of questionable benefit," given that they are terminally ill and that the goal of their care should be comfort rather...